Shared Debt Recovery Scheme - public consultation

Page 1 of 7

Closes 31 Jan 2019


Key elements of the Scheme will be prescribed by the Minister for Health (the Minister) in a legislative instrument. The implementation of the Scheme was delayed until 1 July 2019 to ensure that stakeholders could be consulted on these elements.

Legislative instruments are laws on matters of detail made by the body authorised to do so by the relevant enabling legislation; in this case, the Minister. Examples of legislative instruments include regulations, rules and determinations. A legislative instrument does not require passage through Parliament, but is a disallowable instrument.

The following issues relate to the legislative instrument, and stakeholder input is requested to inform the drafting of the instrument.

Related Information

You may wish to refer to Section 129ACA of the Health Legislation Amendment (Improved Medicare Compliance and Other Measures) Act 2018 throughout this consultation. 

Weblinks to the Improved Medicare Compliance and Other Measures Bill 2018, the full consulation paper, and the Frequently Asked Questions document can be found in the "Related" section of the consultation home page.

1. Full name (including organisation title, eg CEO, if applicable)

2. Email address

If you enter your email address then you will automatically receive an acknowledgement email when you submit your response.

3. Are you responding as an individual or on behalf of an organisation?

4. If you selected an entity other than "individual", please specify the name of the organisation you are responding on behalf of.

5. Do you consent to the Department of Health publishing your responses to this consultation?

More Information

All information related to yourself and/or your organisation can be de-identified before publication.

Please email us if you have questions about the publication of your responses.

Please note that the information you submit in this consultation may be published so your response to this question is important to us. Please contact if you require any further information.